Protective efficacy of IFN-ω and IFN-λs against influenza viruses in induced A549 cells

Acta Virologica

Volumn 59, Issue 4, 2015, Pages 413-417

  Skorvanova L ^a   Svancarova P ^a   Svetlikova D ^a   Betakova T ^a  

^a INSTITUTE OF VIROLOGY   (Slovakia)

Author keywords

Antiviral effect; Influenza virus; Interferon; Replication

Indexed keywords

BETA1A INTERFERON; INTERLEUKIN 28A; INTERLEUKIN 29; RECOMBINANT ALPHA2 INTERFERON; RECOMBINANT INTERFERON; RECOMBINANT INTERLEUKIN 28A; RECOMBINANT INTERLEUKIN 29; RECOMBINANT LAMBDA3 INTERFERON; RECOMBINANT OMEGA INTERFERON; UNCLASSIFIED DRUG; IL28A PROTEIN, HUMAN; IL29 PROTEIN, HUMAN; INTERFERON; INTERFERON OMEGA 1; INTERLEUKIN DERIVATIVE;

A549 CELL LINE; ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; AVIAN INFLUENZA VIRUS; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; HUMAN; HUMAN CELL; INFLUENZA A VIRUS (A/PUERTO RICO/8/1934(H1N1)); INFLUENZA A VIRUS (H7N7); INFLUENZA VIRUS; MDCK CELL LINE; NONHUMAN; PROTECTION; VIRAL PLAQUE ASSAY; COMPARATIVE STUDY; IMMUNOLOGY; INFLUENZA; INFLUENZA A VIRUS (H1N1); PHYSIOLOGY; VIROLOGY;

HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H7N7 SUBTYPE; INFLUENZA, HUMAN; INTERFERON TYPE I; INTERLEUKINS;

EID: 84975497476     PISSN: 0001723X     EISSN: None     Source Type: Journal    
DOI: 10.4149/av_2015_04_413     Document Type: Article

References (34)

1. Adolf GR (1987) Antigenic structure of human interferon omega 1 (interferon alpha II1): comparison with other human interferons. J. Gen. Virol. 68, 1669-1676. http://dx.doi.org/10.1099/0022-1317-68-6-1669
2. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA (2001): Recognition of doublestranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413, 732-738. http://dx.doi.org/10.1038/35099560
3. Au WC, Yeow WS, Pitha PM (2001): Analysis of functional domains of interferon regulatory factor 7 and its association with IRF-3. Virology 280, 273-282. http://dx.doi.org/10.1006/viro.2000.0782
4. Cleary CM, Donnelly RJ, Soh J, Mariano TM, Pestka S (1994): Knockout and reconstitution of a functional human type I interferon receptor complex. J. Biol. Chem. 269, 18747-18749.
5. Dumoutier L, Tounsi A, Michiels T, Sommereyns C, Kotenko SV, Renauld JC (2004): Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling. J. Biol. Chem. 279, 32269-32274. http://dx.doi.org/10.1074/jbc.M404789200
6. Duong FH, Trincucci G, Boldanova T, Calabrese D, Campana B, Krol I, Durand SC, Heydmann L, Zeisel MB, Baumert TF, Heim MH (2014): IFN-λ receptor 1 expression is induced in chronic hepatitis C and correlates with the IFN-λ3 genotype and with nonresponsiveness to IFN-α therapies. J. Exp. Med. 211, 857-868. http://dx.doi.org/10.1084/jem.20131557
7. Files JG, Gray JL, Do LT, Foley WP, Gabe JD, Nestaas E, Pungor E Jr (1998): A novel sensitive and selective bioassay for human type I interferons. J. Interferon Cytokine Res. 8, 1019-1024. http://dx.doi.org/10.1089/jir.1998.18.1019
8. Freeman J, Baglino S, Friborg J, Kraft Z, Gray T, Hill M, McPhee F, Hillson J, Lopez-Talavera JC, Wind-Rotolo M (2014): Pegylated interferons Lambda-1a and alfa-2a display different gene induction and cytokine and chemokine release profiles in whole blood, human hepatocytes and peripheral blood mononuclear cells. J. Viral. Hepat. 21, e1-9. http://dx.doi.org/10.1111/jvh.12243
9. Gad HH, Dellgren C, Hamming OJ, Vends S, Paludan SR, Hartmann R (2009): Interferon-lambda is functionally an interferon but structurally related to the interleukin-10 family. J. Biol. Chem. 284, 20869-20875 http://dx.doi.org/10.1074/jbc.M109.002923
10. Geiss GK, Salvatore M, Tumpey TM, Carter VS, Wang X, Basler CF, Taubenberger JK, Bumgarner RE, Palese P, Katze MG, Garcia-Sastre A (2002): Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proc. Natl. Acad. Sci. USA 99, 10736-10741. http://dx.doi.org/10.1073/pnas.112338099
11. Jagger BW, Wise HM, Kash JC, Walters KA, Wills NM, Xiao YL, Dunfee RL, Schwartzman LM, Ozinsky A, Bell GL, Dalton RM, Lo A, Efstathiou S, Atkins JF, Firth AE, Taubenberger JK, Digard P (2012): An overlapping protein-coding region in influenza A virus segment 3 modulates the host response. Science 337, 199-204. http://dx.doi.org/10.1126/science.1222213
12. Kato H, Sato S, Yoneyama M, Yamamoto M, Uematsu S, Matsui K, Tsujimura T, Takeda K, Fujita T, Takeuchi O, Akira S (2007): Cell type-specific involvement of RIG-I in antiviral response. Immunity 23, 19-28. http://dx.doi.org/10.1016/j.immuni.2005.04.010
13. Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK, Langer JA, Sheikh F, Dickensheets H, Donnelly RP (2003): IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 4, 69-77. http://dx.doi.org/10.1038/ni875
14. Levy DE, Kessler DS, Pine R, Reich N, Darnell JE Jr (1988): Interferon-induced nuclear factors that bind a shared promoter element correlate with positive and negative transcriptional control. Genes Dev. 2, 383-393. http://dx.doi.org/10.1101/gad.2.4.383
15. Li J, Li B, Zhang J, Hou L, Yu C, Fu L, Song X, Yu T, Zhang J, Ren J, Xu C, Chen W (2011): Preparation of CHO cellderived rhIFN-ω-Fc with improved pharmacokinetics. Antiviral Res. 89, 199-203. http://dx.doi.org/10.1016/j.antiviral.2011.01.004
16. Lopušná K, Režuchová I, Betáková T, Skovranová L, Tomašková J, Lukáčiková L, Kabát P (2013): Interferons lambda, new cytokines with antiviral activity. Acta Virol 57, 171-9. http://dx.doi.org/10.4149/av_2013_02_171
17. Mihm S, Spengler U, Amanzada A, Ramadori G (2014): Does the IFN-λ rather than the IFN-α pathway determine the outcome of hepatitis C virus infection? Hepatology 60, 1437-1439. http://dx.doi.org/10.1002/hep.27345
18. Muramoto Y, Noda T, Kawakami E, Akkina R, Kawaoka Y (2013): Identification of novel influenza A virus proteins translated from PA mRNA. J. Virol. 87, 2455-2462. http://dx.doi.org/10.1128/JVI.02656-12
19. Pestka S, Krause CD, Walter MR (2004): Interferons, interferon-like cytokines, and their receptors. Immunol. Rev. 202, 8-32. http://dx.doi.org/10.1111/j.0105-2896.2004.00204.x
20. Rehwinkel J, Tan CP, Goubau D, Schulz O, Pichlmair A, Bier K, Robb N, Vreede F, Barclay W, Fodor E, Reise Sousa C (2010): RIG-I detects viral genomic RNA during negativestrand RNA virus infection. Cell 140, 397-408. http://dx.doi.org/10.1016/j.cell.2010.01.020
21. Sharma S, tenOever BR, Grandvaux N, Zhou GP, Lin R, Hiscott J (2003): IFN: Triggering the interferon antiviral response through an IKK-related pathway. Science 300, 1148-1151. http://dx.doi.org/10.1126/science.1081315
22. Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore TE, Kuestner R, Garrigues U, Birks C, Roraback J, Ostrander C, Dong D, Shin J, Presnell S, Fox B, Haldeman B, Cooper E, Taft D, Gilbert T, Grant FJ, Tackett M, Krivan W, McKnight G, Clegg C, Foster D, Klucher KM (2003): IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat. Immunol. 4, 63-68. http://dx.doi.org/10.1038/ni873
23. Skorvanova L, Betáková T (2013): Cytokines and Influenza Virus. J. Inecf. Dis. Ther. 1, 25-32.
24. Svancarova P, Svetlikova D, Betáková T (2015a): Synergic and antagonistic effect of small hairpin RNAs targeting the NS gene of the influenza A virus in cells and mice. Virus Res. 195, 100-111.
25. Svancarova P, Svetlikova D, Betáková T (2015b): Induction of interferon lambda in influenza A virus infected cells treated with shRNAs against M1 transcript. Acta Virol. 59, 148-155. http://dx.doi.org/10.4149/av_2015_02_148
26. Svetlikova D, Kabat P, Ohradanova A, Pastorek J, Betáková T (2010): Influenza A virus replication is inhibited in IFN-λ2 and IFN-λ3 transfected or stimulated cells. Antiviral Res. 88, 329-333. http://dx.doi.org/10.1016/j.antiviral.2010.10.005
27. Sutejo R, Yeo DS, Myaing MZ, Hui C, Xia J, Ko D, Cheung PC, Tan BH, Sugrue RJ (2012): Activation of type I and III interferon signalling pathways occurs in lung epithelial cells infected with low pathogenic avian influenza viruses. PLoS One 7, e33732. http://dx.doi.org/10.1371/journal.pone.0033732
28. Uzé G, Lutfalla G, Gresser I (1990): Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA. Cell 60, 225-234. http://dx.doi.org/10.1016/0092-8674(90)90738-Z
29. Uzé G, Monneron D (2007): IL-28 and IL-29: newcomers to the interferon family. Biochimie 89, 729-734. http://dx.doi.org/10.1016/j.biochi.2007.01.008
30. Veckman V, Osterlund P, Fagerlund R, Melen K, Matikainen S, Julkunen I (2006): TNF-alpha and IFN-alpha enhance influenza-A-virus-induced chemokine gene expression in human A549 lung epithelial cells. Virology 345, 96-104. http://dx.doi.org/10.1016/j.virol.2005.09.043
31. Wise HM, Foeglein A, Sun J, Dalton RM, Patel S, Howard W, Anderson EC, Barclay WS, Digard P (2009): A complicated message: Identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA. J. Virol. 83, 8021-8031. http://dx.doi.org/10.1128/JVI.00826-09
32. Wise HM, Barbezange C, Jagger BW, Dalton RM, Gog JR, Curran MD, Taubenberger JK, Anderson EC, Digard P (2011): Overlapping signals for translational regulation and packaging of influenza A virus segment 2. Nucleic Acids Res. 39, 7775-7790 http://dx.doi.org/10.1093/nar/gkr487
33. Wise HM, Hutchinson EC, Jagger BW, Stuart AD, Kang ZH, Robb N, Schwartzman LM, Kash JC, Fodor E, Firth AE, Gog JR, Taubenberger JK, Digard P (2012): Identification of a novel splice variant form of the influenza A virus M2 ion channel with an antigenically distinct ectodomain. PLoS Pathog 8, e1002998. http://dx.doi.org/10.1371/journal.ppat.1002998
34. Xu C, Song X, Fu L, Dong D, Wu S, Li G, Yi S, Yu T, Yu R, Hou L, Chen W (2011): Antiviral potential of exogenous human omega interferon to inhibit pandemic 2009 A (H1N1) influenza virus. Viral Immunol. 24, 369-374. http://dx.doi.org/10.1089/vim.2011.0003